Research Interest

Dr. Ma initially proposed a new treatment model to protect female genital organs and functions for patients with cervical cancer, making it possible to preserve female reproductive and endocrine functions by performing neoadjuvant chemotherapy and improving operation methods. He revealed that the disruption of human papillomavirus (HPV) E2 gene was the key mechanism for the processes of HPV integration to cervical carcinogenesis. He first uncovered the susceptibility loci for cervical cancer in Chinese Han population by applying genome-wide association analysis. He also accelerated the network formation for cervical cancer prevention and therapy in China.

Education

Doctor--Clinical medicine--Tongji Medical University, Wuhan, Hubei, P.R. China--1977

Master--Cellular Immune Status in Ovarian Cancer--Tongji Medical University, Wuhan, Hubei, P.R. China--1983

Bachelor--odulation of Chinese Traditional Medicines --Tongji Medical University, Wuhan, Hubei, P.R. China--1987

Oversea Study and Visit

Visiting Scholar,Department of Microbiology, U.T. southwestern Medical ,U.S.A.,1993-01-25-1997-09-25

Academic Memberships

Honours and Awards

Honours and Awards

[1] Shi Y, Li L, Hu Z, Ma Det,al.,A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. ,Nat Genet.2013 Aug;45(8):918-22.,2013,

[2] Sun C, Li N, Yang Z, Zhou B, et,al.,miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition. ,J Natl Cancer Inst. 2013 Oct 29,2013,

[3] Huang X, Bai X, Cao Y, et,al.,Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion. ,J Exp Med.2010 Mar 15;207(3):505-20,2010,

[4] Wu P, Tian Y, Chen G, et,al. , Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells.,Cell Death Differ. 2010;17(1):109-18.,2010,

[5] Ma D,Gerard RD, Li XY, Alizadeh H, Niederkorn JY. ,Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model. ,Blood. 1997 Oct 1; 90(7):2738-46,1997,